|
|
||||||||
AJP - Lung Cellular and Molecular Physiology, Vol 263, Issue 4 446-L453, Copyright © 1992 by American Physiological Society
ARTICLES |
S. W. Chang, D. Dutton, H. L. Wang, L. S. He, R. Stearns, A. Hui, K. M. Giacomini, P. Ortiz de Montellano and N. F. Voelkel
Cardiovascular Pulmonary Research Laboratory, Webb-Waring Lung Institute, University of Colorado Health Sciences Center, Denver 80262.
Lung cytochrome P-450 has been suggested to play a role in hypoxic pulmonary vasoconstriction. We reexamined this hypothesis using specific suicide substrate inhibitors of cytochrome P-450, 1-aminobenzotriazole (1-ABT), and chloramphenicol. In isolated, blood-perfused rat lungs, 1-ABT (0.5 mg/ml) and chloramphenicol (1 mg/ml) inhibited lung microsomal cytochrome P-450 (ethoxycoumarin O-deethylase) activity to 24 and 44% of control, respectively, and blunted hypoxia and angiotensin II-induced vasoconstriction. The depression of vascular contraction by 1-ABT was not due to an effect on calcium channels, since similar concentrations of 1-ABT had no inhibitory activity on electrical field-stimulated contractile response in rabbit papillary muscle strips. However, when 1-ABT was washed out of the lung after preincubation, the vascular reactivity to hypoxia and angiotensin II was restored despite persistent depression of lung cytochrome P-450 activity to 26% of control values. In isolated rat aortic and pulmonary arterial rings, addition of 1-ABT or metyrapone to the organ bath acutely reversed norepinephrine-induced contraction but preincubation with 1-ABT, metyrapone, or chloramphenicol had no effect on subsequent norepinephrine contractions. We conclude that 1-ABT inhibited lung vascular reactivity by a mechanism independent of cytochrome P-450 inhibition or calcium channel blockade and that an intact lung cytochrome P-450 system is not required for hypoxic pulmonary vasoconstriction in rat lungs.
This article has been cited by other articles:
![]() |
Y. Morio, E. P. Carter, M. Oka, and I. F. McMurtry EDHF-mediated vasodilation involves different mechanisms in normotensive and hypertensive rat lungs Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1762 - H1770. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zhu, E. K. Birks, C. A. Dawson, M. Patel, J. R. Falck, K. Presberg, R. J. Roman, and E. R. Jacobs Hypoxic pulmonary vasoconstriction is modified by P-450 metabolites Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1526 - H1533. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. S. Smith The Pharmacology of the Ductus Arteriosus Pharmacol. Rev., March 1, 1998; 50(1): 35 - 58. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |